AR029900A1 - Compuestos derivados de n-(heterociclil)benceno- o piridinsulfonamida, procedimiento para su preparacion y medicamento y composicion farmaceutica que los contienen - Google Patents
Compuestos derivados de n-(heterociclil)benceno- o piridinsulfonamida, procedimiento para su preparacion y medicamento y composicion farmaceutica que los contienenInfo
- Publication number
- AR029900A1 AR029900A1 ARP010101337A ARP010101337A AR029900A1 AR 029900 A1 AR029900 A1 AR 029900A1 AR P010101337 A ARP010101337 A AR P010101337A AR P010101337 A ARP010101337 A AR P010101337A AR 029900 A1 AR029900 A1 AR 029900A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- optionally substituted
- benzene
- procedure
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Compuestos derivados de N-(heterociclil)benceno- o piridinsulfonamida de formula 1 en la cual los sustituyentes tienen, entre, los siguientes significados: X representa o bien un grupo = CR4-, o bien un átomo de nitrogeno, W representa un grupo -(CH2)2-, -(CH2)3-, -(CH2-C:::C o -CH2-CH=CH-, R2 representa un grupo piperidinilo, un grupo 1,2,3,6-tetrahidropiridinilo eventualmente sustituido; un grupo hexahidro-1H-azepinilo, un grupo piperazinilo eventualmente sustituido o un grupo morfolinilo, R3 representa un grupo -COR1, A representa un grupo fenilo eventualmente sustituido, un heterociclo o un grupo ciclopentilo y B representa un grupo piridilo, un grupo aminopirazinilo, un grupo aminopiridazinilo, un grupo pirimidinilo eventualmente sustituido por un grupo amino, un grupo piperidinilo o un grupo aminopiridinilo eventualmente sustituido en la piridina por un grupo (C1-4) alquilo o (C1-4) alcoxi, pudiendo también eventualmente el grupo amino ser sustituido por un grupo (C1-4) alquilo, el procedimiento para su preparacion y un medicamento y una composicion farmacéutica que comprenden a los compuestos. Los compuestos han sido objeto de estudios farmacologicos que han puesto en evidencia sus propiedades antitromboticas y anticoagulantes y su interés como sustancias de actividad terapéutica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0003724A FR2806722B1 (fr) | 2000-03-23 | 2000-03-23 | Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR029900A1 true AR029900A1 (es) | 2003-07-23 |
Family
ID=8848428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010101337A AR029900A1 (es) | 2000-03-23 | 2001-03-22 | Compuestos derivados de n-(heterociclil)benceno- o piridinsulfonamida, procedimiento para su preparacion y medicamento y composicion farmaceutica que los contienen |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US6680329B2 (es) |
| EP (1) | EP1268469B1 (es) |
| JP (1) | JP2003528098A (es) |
| KR (1) | KR100791693B1 (es) |
| CN (1) | CN1183128C (es) |
| AR (1) | AR029900A1 (es) |
| AT (1) | ATE269325T1 (es) |
| AU (2) | AU4661701A (es) |
| BG (1) | BG65863B1 (es) |
| BR (1) | BR0109385A (es) |
| CA (1) | CA2401637C (es) |
| DE (1) | DE60103868T2 (es) |
| DK (1) | DK1268469T3 (es) |
| EA (1) | EA004986B1 (es) |
| EE (1) | EE05084B1 (es) |
| ES (1) | ES2222358T3 (es) |
| FR (1) | FR2806722B1 (es) |
| HK (1) | HK1051537A1 (es) |
| HR (1) | HRP20020762B1 (es) |
| HU (1) | HUP0300695A2 (es) |
| IL (2) | IL151619A0 (es) |
| IS (1) | IS2304B (es) |
| ME (1) | MEP17408A (es) |
| MX (1) | MXPA02009276A (es) |
| NO (1) | NO324835B1 (es) |
| PL (1) | PL204660B1 (es) |
| PT (1) | PT1268469E (es) |
| RS (1) | RS50370B (es) |
| SI (1) | SI1268469T1 (es) |
| SK (1) | SK286687B6 (es) |
| TR (1) | TR200402343T4 (es) |
| TW (1) | TWI290141B (es) |
| UA (1) | UA71667C2 (es) |
| WO (1) | WO2001070736A1 (es) |
| ZA (1) | ZA200206996B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8729107B2 (en) * | 2002-12-06 | 2014-05-20 | Purdue Research Foundation | Pyridines for treating injured mammalian nerve tissue |
| WO2004052291A2 (en) | 2002-12-06 | 2004-06-24 | Purdue Research Foundation | Pyridines for treating injured mammalian nerve tissue |
| US7750162B2 (en) | 2004-04-19 | 2010-07-06 | Daiso Co., Ltd. | Process for preparation of nonnatural amino acid and intermediate thereof |
| EP1739077A4 (en) * | 2004-04-19 | 2008-04-16 | Daiso Co Ltd | PROCESS FOR THE PRODUCTION OF NON-NATURAL AMINO ACIDS AND INTERMEDIATES THEREFOR |
| GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
| US8586748B2 (en) * | 2008-04-09 | 2013-11-19 | Boehringer Ingelheim International Gmbh | 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10 |
| WO2009142984A1 (en) * | 2008-05-22 | 2009-11-26 | Boehringer Ingelheim International Gmbh | Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them |
| WO2011094496A2 (en) * | 2010-01-28 | 2011-08-04 | The Medicines Company | Trypsin-like serine protease inhibitors, and their preparation and use |
| FR2981071B1 (fr) * | 2011-10-10 | 2014-02-07 | Centre Nat Rech Scient | Synthese versatile et stereospecifique d'acides amines gamma,delta-insatures par la reaction de wittig |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2727410B1 (fr) * | 1994-11-25 | 1996-12-20 | Synthelabo | Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese |
| FR2728570B1 (fr) * | 1994-12-23 | 1997-04-11 | Synthelabo | Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique |
| FR2756285B1 (fr) * | 1996-11-22 | 1998-12-18 | Synthelabo | Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique |
| FR2756220B1 (fr) * | 1996-11-27 | 1998-12-24 | Lorraine Laminage | Roue pour vehicule terrestre a moteur |
| FR2771094B1 (fr) * | 1997-11-19 | 2000-02-04 | Synthelabo | Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique |
-
2000
- 2000-03-23 FR FR0003724A patent/FR2806722B1/fr not_active Expired - Fee Related
-
2001
- 2001-03-22 KR KR1020027012432A patent/KR100791693B1/ko not_active IP Right Cessation
- 2001-03-22 EE EEP200200540A patent/EE05084B1/xx not_active IP Right Cessation
- 2001-03-22 PL PL364988A patent/PL204660B1/pl not_active IP Right Cessation
- 2001-03-22 ME MEP-174/08A patent/MEP17408A/xx unknown
- 2001-03-22 RS YUP-670/02A patent/RS50370B/sr unknown
- 2001-03-22 UA UA2002097272A patent/UA71667C2/uk unknown
- 2001-03-22 EP EP01919537A patent/EP1268469B1/fr not_active Expired - Lifetime
- 2001-03-22 ES ES01919537T patent/ES2222358T3/es not_active Expired - Lifetime
- 2001-03-22 CN CNB018084974A patent/CN1183128C/zh not_active Expired - Fee Related
- 2001-03-22 AR ARP010101337A patent/AR029900A1/es active IP Right Grant
- 2001-03-22 BR BR0109385-1A patent/BR0109385A/pt not_active Application Discontinuation
- 2001-03-22 MX MXPA02009276A patent/MXPA02009276A/es active IP Right Grant
- 2001-03-22 AT AT01919537T patent/ATE269325T1/de active
- 2001-03-22 JP JP2001568937A patent/JP2003528098A/ja not_active Ceased
- 2001-03-22 TR TR2004/02343T patent/TR200402343T4/xx unknown
- 2001-03-22 CA CA002401637A patent/CA2401637C/en not_active Expired - Fee Related
- 2001-03-22 EA EA200200838A patent/EA004986B1/ru not_active IP Right Cessation
- 2001-03-22 SK SK1351-2002A patent/SK286687B6/sk not_active IP Right Cessation
- 2001-03-22 WO PCT/FR2001/000861 patent/WO2001070736A1/fr active IP Right Grant
- 2001-03-22 HU HU0300695A patent/HUP0300695A2/hu unknown
- 2001-03-22 SI SI200130152T patent/SI1268469T1/xx unknown
- 2001-03-22 US US10/221,404 patent/US6680329B2/en not_active Expired - Fee Related
- 2001-03-22 TW TW090106733A patent/TWI290141B/zh active
- 2001-03-22 DE DE60103868T patent/DE60103868T2/de not_active Expired - Lifetime
- 2001-03-22 AU AU4661701A patent/AU4661701A/xx active Pending
- 2001-03-22 AU AU2001246617A patent/AU2001246617B2/en not_active Ceased
- 2001-03-22 IL IL15161901A patent/IL151619A0/xx unknown
- 2001-03-22 PT PT01919537T patent/PT1268469E/pt unknown
- 2001-03-22 DK DK01919537T patent/DK1268469T3/da active
-
2002
- 2002-08-30 IS IS6535A patent/IS2304B/is unknown
- 2002-08-30 ZA ZA200206996A patent/ZA200206996B/en unknown
- 2002-09-04 IL IL151619A patent/IL151619A/en not_active IP Right Cessation
- 2002-09-19 NO NO20024496A patent/NO324835B1/no not_active IP Right Cessation
- 2002-09-19 HR HR20020762A patent/HRP20020762B1/xx not_active IP Right Cessation
- 2002-09-20 BG BG107130A patent/BG65863B1/bg unknown
-
2003
- 2003-05-27 HK HK03103771A patent/HK1051537A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0300894A2 (hu) | Szubsztituált béta-karbolinok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| BR0108395A (pt) | Derivados de pirrolopirimidinona, processos de preparação e uso | |
| NO20064347L (no) | Substituerte 1,2,3,4-tetrahydroisokinolinderivater | |
| ATE452129T1 (de) | N-phenyl-2-pyrimidine-amine derivatives | |
| LV10270A (lv) | 2-[(2-Piridinil)metilsulfinil-(vai sulfonil)]-1H-benzimidazol-1-ila atvasinajumi to iegusanas panemiens farmaceitiska kompozicija uz to bazes pielietojums | |
| BRPI0418251B8 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
| ATE269846T1 (de) | N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen | |
| EA200501268A1 (ru) | Ингибирующие вич 1,2,4-триазины | |
| NO20073059L (no) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| NO20060973L (no) | Pyridylderivater og deres anvendelse som tempeutiske midler | |
| DE602004030222D1 (de) | 2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen | |
| BRPI0114870B8 (pt) | uso de 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il)pirimidin-2-amino)fenil]-benzamida para a fabricação de composições farmacêuticas para tratamento de tumores estromais gastrointestinais | |
| BRPI0418939A (pt) | derivados de nicotinamida e sua utilização como agentes terapêuticos | |
| YU45095A (sh) | Derivati benzimidazola, postupci za njihovo prirpremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija | |
| MY146403A (en) | F, g, h, i and k crystal forms of imatinib mesylate | |
| DK1259240T3 (da) | Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme | |
| SE0301446D0 (sv) | New Compounds | |
| AR029900A1 (es) | Compuestos derivados de n-(heterociclil)benceno- o piridinsulfonamida, procedimiento para su preparacion y medicamento y composicion farmaceutica que los contienen | |
| FR2744452B1 (fr) | Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations | |
| JOP20220152A1 (ar) | مشتقات 3-(5- ميثوكسي -1- أوكسو أيزو إندولين -2- يل) بيبريدين -2، 6- دايون واستخداماتها | |
| ES2086436T3 (es) | Nuevos eteres y tioeteres de piperidilo inhibidores de la biosintesis de colesterol. | |
| DE60042831D1 (de) | Pharmazeutisch aktive sulfonylaminosäurederivate | |
| BRPI0414777A (pt) | compostos, composições farmacêuticas, uso de um ou mais compostos, e, método de tratar um paciente que sofre de um distúrbio | |
| BR0211995A (pt) | Preparados de combinação de derivados de propanolamina substituìdos por arila com outras substâncias ativas e sua aplicação |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |